Kelsey Moody on leadership: Be coachable and hire people who can teach you

Posted on Posted in Uncategorized

Link to original article By Stan Linhorst StanLinhorst@gmail.com, syracuse.com Kelsey Moody was a medical student at Upstate Medical University when he landed a $540,000 research grant and set up his own pharmaceutical research company. “After we had cleared our first million dollars in funding for the company, I had to choose: Did I want to finish my medical […]

Ichor featured in News Channel 9 segment

Posted on Posted in Uncategorized

Please click here for video. LAFAYETTE, N.Y. (WSYR-TV) – One Central New York start-up is looking to start human trials on their solution to macular degeneration– a disease that’s a leading cause of vision loss for over 10 million Americans. Ichor Therapeutics, based in LaFayette, is looking to make a name for itself. “There’s no […]

Ichor nabs $600,000 program investment and new partnerships in wake of company expansion and promising early results

Posted on Posted in Uncategorized

Ichor builds new partnerships and lands $600k investment for its Age-related Macular Degeneration (AMD) research initiative, which has shown positive early results. Age-related Macular Degeneration (AMD) is a presently incurable eye condition leading to partial loss of vision and affects as many as 15 million Americans and millions more globally. AMD has a significant impact […]

GLP/GMP is next for Ichor

Posted on Posted in Uncategorized

In March we signed on a new investor, Roger Bagg (you may have seen our press release over at MedTech, or the Town of Lafayette Newsletter – we’re glad everyone else was as excited as we were!). Roger is an ideal investor for Ichor. He has experience investing in other Biotech firms both in the US and the UK, […]

Ichor lands $1.35 million, attracts international investors

Posted on Posted in Uncategorized

FOR IMMEDIATE RELEASE LaFayette, New York, March 2nd, 2016 Ichor Therapeutics, a local biotechnology company focusing on therapeutic interventions for age-related disease, receives $1.35 million in new funding — including $1 million from European investors — and begins a 4-fold expansion of research capabilities in LaFayette, NY to engage in FDA compliant pre-clinical research. Ichor was […]